# MONOBASIC POTASSIUM PHOSPHATE

URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid0035667
Categories: beauty, cleaning, food, industrial, pharma
Functions: Biocide, Corrosion inhibitor, Flavouring and nutrient, Other, Phosphate source, Soil amendments, Thickening agent, pH regulating agent
Identifier: DTXSID0035667

> MONOBASIC POTASSIUM PHOSPHATE is used as biocide / corrosion inhibitor. EPA CPDat observed this chemical in 621 composition records across product categories including Construction and building materials, Laboratory supplies, Cleaning products and household care. Assessed from 26 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: EPA CPDat observed this chemical in 621 composition records across product categories including Construction and building materials, Laboratory supplies, Cleaning products and household care.

## Regulatory status

- US: commercial use observed — EPA CPDat observed this chemical in 621 composition records across product categories including Construction and building materials, Laboratory supplies, Cleaning products and household care. EPA CPDat classifies this chemical for functional uses including pH regulating agent, Corrosion inhibitor, Phosphate source.
- US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: SOLUTION; Potency: 0.2 %w/w
- US: inactive ingredient database — Route: INTRA-ARTICULAR; Dosage form: INJECTION; Potency: 0.3 %w/v
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION; Potency: 0.3 %w/v
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION; Potency: 68 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 110 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Potency: 1.36 %w/v
- US: inactive ingredient database — Route: INTRAVESICAL; Dosage form: INJECTION, SOLUTION; Potency: 29.2 mg
- US: inactive ingredient database — Route: NASAL; Dosage form: SOLUTION; Potency: 680 mg
- US: inactive ingredient database — Route: NASAL; Dosage form: SPRAY; Maximum daily exposure: 3 mg
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION; Potency: 0.2 %w/w
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SUSPENSION; Potency: 0.44 %w/w
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, COATED PELLETS; Maximum daily exposure: 272 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE PELLETS; Maximum daily exposure: 272 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 287 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Potency: 50 mg/5ml
- US: inactive ingredient database — Route: ORAL; Dosage form: SYRUP; Maximum daily exposure: 19 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Potency: 25 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Potency: 4 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION; Maximum daily exposure: 8 mg
- US: marketed drug occurrence — FDA NDC lists this ingredient in 17 active drug products and 17 total products.
- US: marketed drug occurrence — FDA NDC lists this ingredient in 20 active drug products and 21 total products.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as chemical.

_Assessed by Greenveil._